Taken together, these data suggest that PD astrocytes are more responsive to inflammatory stimuli than control cells and that lipocalin-2, a known mediator of reactive astrocytosis19 may play a pathogenic role in PD. This evidence concerns the gene LCN2 and Parkinson disease.